Effect of Magnesium Supplement in Early Pregnancy After ICSI
NCT ID: NCT03398031
Last Updated: 2018-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
180 participants
INTERVENTIONAL
2017-06-01
2018-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is it Safe to do Endometrial Injury in the Same ICSI Cycle: A Randomized Controlled Trial
NCT05987995
Effect of Dilatation and Curettage on the Endometrial Receptivity
NCT03485235
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
NCT03683771
Uterine Peristalsis in IVF
NCT06036459
Aspiration of Excessive Endometrial Fluid at the Day of Ovum Retrieval Plus Diosmin in (ICSI) Cycles
NCT02158000
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
so magnesium supplement start after biochemical diagnosis of pregnancy and throughout the 1st trimester
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Magnesium supplement
90 female pregnant after ICSI after biochemical diagnosis of pregnancy will receive 500 mg magnesium supplement
Magnesium Oxide
After biochemical diagnosis of pregnancy each participant will receive magnesium plus 500 mg tablet once daily till the end of the 1st trimester
placebo
90 female pregnant after ICSI after biochemical diagnosis of pregnancy will receive placebo oral tablet
Placebo Oral Tablet
After biochemical diagnosis of pregnancy each participant will receive placebo tablet once daily till the end of the 1st trimester
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnesium Oxide
After biochemical diagnosis of pregnancy each participant will receive magnesium plus 500 mg tablet once daily till the end of the 1st trimester
Placebo Oral Tablet
After biochemical diagnosis of pregnancy each participant will receive placebo tablet once daily till the end of the 1st trimester
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 25\_30
* females pregnant after ICSI after biochemical diagnosis of pregnancy
Exclusion Criteria
* abnormality in uterine cavity detected by hysteroscopic evaluation pre ICSI and not treated
* hydrosalpinx
25 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Radwa Rasheedy Ali
lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AinShams university maternity hospital
Cairo, Abbassya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
ahmed m Abbas, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ashams university
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.